← 產業報告目錄
Veterinary Autogenous Vaccines Industry Research Report 2026
出版商 APO Research產業別 Healthcare & Life Sciences出版日期 2026-01-02頁數 138報告編號 APO-f7f4e58a48
授權報價
| Single User | $2,950 USD |
| Multi User | $4,430 USD |
| Enterprise | $5,900 USD |
報告摘要
The global Veterinary Autogenous Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Veterinary Autogenous Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Veterinary Autogenous Vaccines is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
The Asia Pacific market for Veterinary Autogenous Vaccines is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Veterinary Autogenous Vaccines include ZOETIS, Vaxxinova, UVAXX, Phibro Animal Health Corporation, Newport Laboratories, LOHMANN TIERZUCHT, Hygieia Biological Laboratories, Genova Labs and Gallant Custom Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Veterinary Autogenous Vaccines market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Autogenous Vaccines Market by Company
ZOETIS
Vaxxinova
UVAXX
Phibro Animal Health Corporation
Newport Laboratories
LOHMANN TIERZUCHT
Hygieia Biological Laboratories
Genova Labs
Gallant Custom Laboratories
Epitopix
Elanco Animal Health
Dyntec
Deltamune Animal Health
Ceva Biovac
Boehringer Ingelheim
Bimeda
Addison Biological Laboratory
Veterinary Autogenous Vaccines Segment by Type
Pet Vaccine
Livestock Vaccine
Veterinary Autogenous Vaccines Segment by Application
Research Facility
Ranches
Pet Clinic
Others
Veterinary Autogenous Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Autogenous Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Autogenous Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Autogenous Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Autogenous Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Autogenous Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Autogenous Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
目錄 Table of Contents
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Veterinary Autogenous Vaccines Market Size (2021-2032)
2.2.2 Global Veterinary Autogenous Vaccines Sales (2021-2032)
2.2.3 Global Veterinary Autogenous Vaccines Market Average Price (2021-2032)
2.3 Veterinary Autogenous Vaccines by Type
2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
2.3.2 Pet Vaccine
2.3.3 Livestock Vaccine
2.4 Veterinary Autogenous Vaccines by Application
2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
2.4.2 Research Facility
2.4.3 Ranches
2.4.4 Pet Clinic
2.4.5 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Veterinary Autogenous Vaccines Market Competitive Situation by Manufacturers (2021 Versus 2025)
3.2 Global Veterinary Autogenous Vaccines Sales (W Units) of Manufacturers (2021-2026)
3.3 Global Veterinary Autogenous Vaccines Revenue of Manufacturers (2021-2026)
3.4 Global Veterinary Autogenous Vaccines Average Price by Manufacturers (2021-2026)
3.5 Global Veterinary Autogenous Vaccines Industry Ranking, 2024 VS 2025 VS 2026
3.6 Global Manufacturers of Veterinary Autogenous Vaccines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Veterinary Autogenous Vaccines, Product Type & Application
3.8 Global Manufacturers of Veterinary Autogenous Vaccines, Established Date
3.9 Global Veterinary Autogenous Vaccines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 ZOETIS
4.1.1 ZOETIS Company Information
4.1.2 ZOETIS Business Overview
4.1.3 ZOETIS Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.1.4 ZOETIS Veterinary Autogenous Vaccines Product Portfolio
4.1.5 ZOETIS Recent Developments
4.2 Vaxxinova
4.2.1 Vaxxinova Company Information
4.2.2 Vaxxinova Business Overview
4.2.3 Vaxxinova Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.2.4 Vaxxinova Veterinary Autogenous Vaccines Product Portfolio
4.2.5 Vaxxinova Recent Developments
4.3 UVAXX
4.3.1 UVAXX Company Information
4.3.2 UVAXX Business Overview
4.3.3 UVAXX Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.3.4 UVAXX Veterinary Autogenous Vaccines Product Portfolio
4.3.5 UVAXX Recent Developments
4.4 Phibro Animal Health Corporation
4.4.1 Phibro Animal Health Corporation Company Information
4.4.2 Phibro Animal Health Corporation Business Overview
4.4.3 Phibro Animal Health Corporation Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.4.4 Phibro Animal Health Corporation Veterinary Autogenous Vaccines Product Portfolio
4.4.5 Phibro Animal Health Corporation Recent Developments
4.5 Newport Laboratories
4.5.1 Newport Laboratories Company Information
4.5.2 Newport Laboratories Business Overview
4.5.3 Newport Laboratories Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.5.4 Newport Laboratories Veterinary Autogenous Vaccines Product Portfolio
4.5.5 Newport Laboratories Recent Developments
4.6 LOHMANN TIERZUCHT
4.6.1 LOHMANN TIERZUCHT Company Information
4.6.2 LOHMANN TIERZUCHT Business Overview
4.6.3 LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.6.4 LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Product Portfolio
4.6.5 LOHMANN TIERZUCHT Recent Developments
4.7 Hygieia Biological Laboratories
4.7.1 Hygieia Biological Laboratories Company Information
4.7.2 Hygieia Biological Laboratories Business Overview
4.7.3 Hygieia Biological Laboratories Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.7.4 Hygieia Biological Laboratories Veterinary Autogenous Vaccines Product Portfolio
4.7.5 Hygieia Biological Laboratories Recent Developments
4.8 Genova Labs
4.8.1 Genova Labs Company Information
4.8.2 Genova Labs Business Overview
4.8.3 Genova Labs Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.8.4 Genova Labs Veterinary Autogenous Vaccines Product Portfolio
4.8.5 Genova Labs Recent Developments
4.9 Gallant Custom Laboratories
4.9.1 Gallant Custom Laboratories Company Information
4.9.2 Gallant Custom Laboratories Business Overview
4.9.3 Gallant Custom Laboratories Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.9.4 Gallant Custom Laboratories Veterinary Autogenous Vaccines Product Portfolio
4.9.5 Gallant Custom Laboratories Recent Developments
4.10 Epitopix
4.10.1 Epitopix Company Information
4.10.2 Epitopix Business Overview
4.10.3 Epitopix Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.10.4 Epitopix Veterinary Autogenous Vaccines Product Portfolio
4.10.5 Epitopix Recent Developments
4.11 Elanco Animal Health
4.11.1 Elanco Animal Health Company Information
4.11.2 Elanco Animal Health Business Overview
4.11.3 Elanco Animal Health Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.11.4 Elanco Animal Health Veterinary Autogenous Vaccines Product Portfolio
4.11.5 Elanco Animal Health Recent Developments
4.12 Dyntec
4.12.1 Dyntec Company Information
4.12.2 Dyntec Business Overview
4.12.3 Dyntec Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.12.4 Dyntec Veterinary Autogenous Vaccines Product Portfolio
4.12.5 Dyntec Recent Developments
4.13 Deltamune Animal Health
4.13.1 Deltamune Animal Health Company Information
4.13.2 Deltamune Animal Health Business Overview
4.13.3 Deltamune Animal Health Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.13.4 Deltamune Animal Health Veterinary Autogenous Vaccines Product Portfolio
4.13.5 Deltamune Animal Health Recent Developments
4.14 Ceva Biovac
4.14.1 Ceva Biovac Company Information
4.14.2 Ceva Biovac Business Overview
4.14.3 Ceva Biovac Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.14.4 Ceva Biovac Veterinary Autogenous Vaccines Product Portfolio
4.14.5 Ceva Biovac Recent Developments
4.15 Boehringer Ingelheim
4.15.1 Boehringer Ingelheim Company Information
4.15.2 Boehringer Ingelheim Business Overview
4.15.3 Boehringer Ingelheim Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.15.4 Boehringer Ingelheim Veterinary Autogenous Vaccines Product Portfolio
4.15.5 Boehringer Ingelheim Recent Developments
4.16 Bimeda
4.16.1 Bimeda Company Information
4.16.2 Bimeda Business Overview
4.16.3 Bimeda Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.16.4 Bimeda Veterinary Autogenous Vaccines Product Portfolio
4.16.5 Bimeda Recent Developments
4.17 Addison Biological Laboratory
4.17.1 Addison Biological Laboratory Company Information
4.17.2 Addison Biological Laboratory Business Overview
4.17.3 Addison Biological Laboratory Veterinary Autogenous Vaccines Sales, Revenue and Gross Margin (2021-2026)
4.17.4 Addison Biological Laboratory Veterinary Autogenous Vaccines Product Portfolio
4.17.5 Addison Biological Laboratory Recent Developments
5 Global Veterinary Autogenous Vaccines Market Scenario by Region
5.1 Global Veterinary Autogenous Vaccines Market Size by Region: 2021 VS 2025 VS 2032
5.2 Global Veterinary Autogenous Vaccines Sales by Region: 2021-2032
5.2.1 Global Veterinary Autogenous Vaccines Sales by Region: 2021-2026
5.2.2 Global Veterinary Autogenous Vaccines Sales by Region: 2027-2032
5.3 Global Veterinary Autogenous Vaccines Revenue by Region: 2021-2032
5.3.1 Global Veterinary Autogenous Vaccines Revenue by Region: 2021-2026
5.3.2 Global Veterinary Autogenous Vaccines Revenue by Region: 2027-2032
5.4 North America Veterinary Autogenous Vaccines Market Facts & Figures by Country
5.4.1 North America Veterinary Autogenous Vaccines Market Size by Country: 2021 VS 2025 VS 2032
5.4.2 North America Veterinary Autogenous Vaccines Sales by Country (2021-2032)
5.4.3 North America Veterinary Autogenous Vaccines Revenue by Country (2021-2032)
5.4.4 United States
5.4.5 Canada
5.5 Europe Veterinary Autogenous Vaccines Market Facts & Figures by Country
5.5.1 Europe Veterinary Autogenous Vaccines Market Size by Country: 2021 VS 2025 VS 2032
5.5.2 Europe Veterinary Autogenous Vaccines Sales by Country (2021-2032)
5.5.3 Europe Veterinary Autogenous Vaccines Revenue by Country (2021-2032)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Veterinary Autogenous Vaccines Market Facts & Figures by Country
5.6.1 Asia Pacific Veterinary Autogenous Vaccines Market Size by Country: 2021 VS 2025 VS 2032
5.6.2 Asia Pacific Veterinary Autogenous Vaccines Sales by Country (2021-2032)
5.6.3 Asia Pacific Veterinary Autogenous Vaccines Revenue by Country (2021-2032)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Veterinary Autogenous Vaccines Market Facts & Figures by Country
5.7.1 South America Veterinary Autogenous Vaccines Market Size by Country: 2021 VS 2025 VS 2032
5.7.2 South America Veterinary Autogenous Vaccines Sales by Country (2021-2032)
5.7.3 South America Veterinary Autogenous Vaccines Revenue by Country (2021-2032)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Veterinary Autogenous Vaccines Market Facts & Figures by Country
5.8.1 Middle East and Africa Veterinary Autogenous Vaccines Market Size by Country: 2021 VS 2025 VS 2032
5.8.2 Middle East and Africa Veterinary Autogenous Vaccines Sales by Country (2021-2032)
5.8.3 Middle East and Africa Veterinary Autogenous Vaccines Revenue by Country (2021-2032)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Veterinary Autogenous Vaccines Sales by Type (2021-2032)
6.1.1 Global Veterinary Autogenous Vaccines Sales by Type (2021-2032) & (W Units)
6.1.2 Global Veterinary Autogenous Vaccines Sales Market Share by Type (2021-2032)
6.2 Global Veterinary Autogenous Vaccines Revenue by Type (2021-2032)
6.2.1 Global Veterinary Autogenous Vaccines Sales by Type (2021-2032) & (US$ Million)
6.2.2 Global Veterinary Autogenous Vaccines Revenue Market Share by Type (2021-2032)
6.3 Global Veterinary Autogenous Vaccines Price by Type (2021-2032)
7 Segment by Application
7.1 Global Veterinary Autogenous Vaccines Sales by Application (2021-2032)
7.1.1 Global Veterinary Autogenous Vaccines Sales by Application (2021-2032) & (W Units)
7.1.2 Global Veterinary Autogenous Vaccines Sales Market Share by Application (2021-2032)
7.2 Global Veterinary Autogenous Vaccines Revenue by Application (2021-2032)
7.2.1 Global Veterinary Autogenous Vaccines Sales by Application (2021-2032) & (US$ Million)
7.2.2 Global Veterinary Autogenous Vaccines Revenue Market Share by Application (2021-2032)
7.3 Global Veterinary Autogenous Vaccines Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Veterinary Autogenous Vaccines Value Chain Analysis
8.1.1 Veterinary Autogenous Vaccines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Veterinary Autogenous Vaccines Production Mode & Process
8.2 Veterinary Autogenous Vaccines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Veterinary Autogenous Vaccines Distributors
8.2.3 Veterinary Autogenous Vaccines Customers
9 Global Veterinary Autogenous Vaccines Analyzing Market Dynamics
9.1 Veterinary Autogenous Vaccines Industry Trends
9.2 Veterinary Autogenous Vaccines Industry Drivers
9.3 Veterinary Autogenous Vaccines Industry Opportunities and Challenges
9.4 Veterinary Autogenous Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer
圖表清單 List of Tables & Figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Veterinary Autogenous Vaccines Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025)
Table 6. Global Veterinary Autogenous Vaccines Sales (W Units) of Manufacturers (2021-2026)
Table 7. Global Veterinary Autogenous Vaccines Sales Market Share by Manufacturers (2021-2026)
Table 8. Global Veterinary Autogenous Vaccines Revenue of Manufacturers (2021-2026)
Table 9. Global Veterinary Autogenous Vaccines Revenue Share by Manufacturers (2021-2026)
Table 10. Global Market Veterinary Autogenous Vaccines Average Price (US$/Unit) of Manufacturers (2021-2026)
Table 11. Global Veterinary Autogenous Vaccines Industry Ranking, 2024 VS 2025 VS 2026
Table 12. Global Manufacturers of Veterinary Autogenous Vaccines, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Veterinary Autogenous Vaccines, Product Type & Application
Table 14. Global Veterinary Autogenous Vaccines Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Veterinary Autogenous Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. ZOETIS Company Information
Table 19. ZOETIS Business Overview
Table 20. ZOETIS Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 21. ZOETIS Veterinary Autogenous Vaccines Product Portfolio
Table 22. ZOETIS Recent Developments
Table 23. Vaxxinova Company Information
Table 24. Vaxxinova Business Overview
Table 25. Vaxxinova Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 26. Vaxxinova Veterinary Autogenous Vaccines Product Portfolio
Table 27. Vaxxinova Recent Developments
Table 28. UVAXX Company Information
Table 29. UVAXX Business Overview
Table 30. UVAXX Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 31. UVAXX Veterinary Autogenous Vaccines Product Portfolio
Table 32. UVAXX Recent Developments
Table 33. Phibro Animal Health Corporation Company Information
Table 34. Phibro Animal Health Corporation Business Overview
Table 35. Phibro Animal Health Corporation Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 36. Phibro Animal Health Corporation Veterinary Autogenous Vaccines Product Portfolio
Table 37. Phibro Animal Health Corporation Recent Developments
Table 38. Newport Laboratories Company Information
Table 39. Newport Laboratories Business Overview
Table 40. Newport Laboratories Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 41. Newport Laboratories Veterinary Autogenous Vaccines Product Portfolio
Table 42. Newport Laboratories Recent Developments
Table 43. LOHMANN TIERZUCHT Company Information
Table 44. LOHMANN TIERZUCHT Business Overview
Table 45. LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 46. LOHMANN TIERZUCHT Veterinary Autogenous Vaccines Product Portfolio
Table 47. LOHMANN TIERZUCHT Recent Developments
Table 48. Hygieia Biological Laboratories Company Information
Table 49. Hygieia Biological Laboratories Business Overview
Table 50. Hygieia Biological Laboratories Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 51. Hygieia Biological Laboratories Veterinary Autogenous Vaccines Product Portfolio
Table 52. Hygieia Biological Laboratories Recent Developments
Table 53. Genova Labs Company Information
Table 54. Genova Labs Business Overview
Table 55. Genova Labs Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 56. Genova Labs Veterinary Autogenous Vaccines Product Portfolio
Table 57. Genova Labs Recent Developments
Table 58. Gallant Custom Laboratories Company Information
Table 59. Gallant Custom Laboratories Business Overview
Table 60. Gallant Custom Laboratories Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 61. Gallant Custom Laboratories Veterinary Autogenous Vaccines Product Portfolio
Table 62. Gallant Custom Laboratories Recent Developments
Table 63. Epitopix Company Information
Table 64. Epitopix Business Overview
Table 65. Epitopix Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 66. Epitopix Veterinary Autogenous Vaccines Product Portfolio
Table 67. Epitopix Recent Developments
Table 68. Elanco Animal Health Company Information
Table 69. Elanco Animal Health Business Overview
Table 70. Elanco Animal Health Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 71. Elanco Animal Health Veterinary Autogenous Vaccines Product Portfolio
Table 72. Elanco Animal Health Recent Developments
Table 73. Dyntec Company Information
Table 74. Dyntec Business Overview
Table 75. Dyntec Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Dyntec Veterinary Autogenous Vaccines Product Portfolio
Table 77. Dyntec Recent Developments
Table 78. Deltamune Animal Health Company Information
Table 79. Deltamune Animal Health Business Overview
Table 80. Deltamune Animal Health Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Deltamune Animal Health Veterinary Autogenous Vaccines Product Portfolio
Table 82. Deltamune Animal Health Recent Developments
Table 83. Ceva Biovac Company Information
Table 84. Ceva Biovac Business Overview
Table 85. Ceva Biovac Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Ceva Biovac Veterinary Autogenous Vaccines Product Portfolio
Table 87. Ceva Biovac Recent Developments
Table 88. Boehringer Ingelheim Company Information
Table 89. Boehringer Ingelheim Business Overview
Table 90. Boehringer Ingelheim Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Boehringer Ingelheim Veterinary Autogenous Vaccines Product Portfolio
Table 92. Boehringer Ingelheim Recent Developments
Table 93. Bimeda Company Information
Table 94. Bimeda Business Overview
Table 95. Bimeda Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Bimeda Veterinary Autogenous Vaccines Product Portfolio
Table 97. Bimeda Recent Developments
Table 98. Addison Biological Laboratory Company Information
Table 99. Addison Biological Laboratory Business Overview
Table 100. Addison Biological Laboratory Veterinary Autogenous Vaccines Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Addison Biological Laboratory Veterinary Autogenous Vaccines Product Portfolio
Table 102. Addison Biological Laboratory Recent Developments
Table 103. Global Veterinary Autogenous Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 104. Global Veterinary Autogenous Vaccines Sales by Region (2021-2026) & (W Units)
Table 105. Global Veterinary Autogenous Vaccines Sales Market Share by Region (2021-2026)
Table 106. Global Veterinary Autogenous Vaccines Sales by Region (2027-2032) & (W Units)
Table 107. Global Veterinary Autogenous Vaccines Sales Market Share by Region (2027-2032)
Table 108. Global Veterinary Autogenous Vaccines Revenue by Region (2021-2026) & (US$ Million)
Table 109. Global Veterinary Autogenous Vaccines Revenue Market Share by Region (2021-2026)
Table 110. Global Veterinary Autogenous Vaccines Revenue by Region (2027-2032) & (US$ Million)
Table 111. Global Veterinary Autogenous Vaccines Revenue Market Share by Region (2027-2032)
Table 112. North America Veterinary Autogenous Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 113. North America Veterinary Autogenous Vaccines Sales by Country (2021-2026) & (W Units)
Table 114. North America Veterinary Autogenous Vaccines Sales by Country (2027-2032) & (W Units)
Table 115. North America Veterinary Autogenous Vaccines Revenue by Country (2021-2026) & (US$ Million)
Table 116. North America Veterinary Autogenous Vaccines Revenue by Country (2027-2032) & (US$ Million)
Table 117. Europe Veterinary Autogenous Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 118. Europe Veterinary Autogenous Vaccines Sales by Country (2021-2026) & (W Units)
Table 119. Europe Veterinary Autogenous Vaccines Sales by Country (2027-2032) & (W Units)
Table 120. Europe Veterinary Autogenous Vaccines Revenue by Country (2021-2026) & (US$ Million)
Table 121. Europe Veterinary Autogenous Vaccines Revenue by Country (2027-2032) & (US$ Million)
Table 122. Asia Pacific Veterinary Autogenous Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 123. Asia Pacific Veterinary Autogenous Vaccines Sales by Country (2021-2026) & (W Units)
Table 124. Asia Pacific Veterinary Autogenous Vaccines Sales by Country (2027-2032) & (W Units)
Table 125. Asia Pacific Veterinary Autogenous Vaccines Revenue by Country (2021-2026) & (US$ Million)
Table 126. Asia Pacific Veterinary Autogenous Vaccines Revenue by Country (2027-2032) & (US$ Million)
Table 127. South America Veterinary Autogenous Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 128. South America Veterinary Autogenous Vaccines Sales by Country (2021-2026) & (W Units)
Table 129. South America Veterinary Autogenous Vaccines Sales by Country (2027-2032) & (W Units)
Table 130. South America Veterinary Autogenous Vaccines Revenue by Country (2021-2026) & (US$ Million)
Table 131. South America Veterinary Autogenous Vaccines Revenue by Country (2027-2032) & (US$ Million)
Table 132. Middle East and Africa Veterinary Autogenous Vaccines Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 133. Middle East and Africa Veterinary Autogenous Vaccines Sales by Country (2021-2026) & (W Units)
Table 134. Middle East and Africa Veterinary Autogenous Vaccines Sales by Country (2027-2032) & (W Units)
Table 135. Middle East and Africa Veterinary Autogenous Vaccines Revenue by Country (2021-2026) & (US$ Million)
Table 136. Middle East and Africa Veterinary Autogenous Vaccines Revenue by Country (2027-2032) & (US$ Million)
Table 137. Global Veterinary Autogenous Vaccines Sales by Type (2021-2026) & (W Units)
Table 138. Global Veterinary Autogenous Vaccines Sales by Type (2027-2032) & (W Units)
Table 139. Global Veterinary Autogenous Vaccines Sales Market Share by Type (2021-2026)
Table 140. Global Veterinary Autogenous Vaccines Sales Market Share by Type (2027-2032)
Table 141. Global Veterinary Autogenous Vaccines Revenue by Type (2021-2026) & (US$ Million)
Table 142. Global Veterinary Autogenous Vaccines Revenue by Type (2027-2032) & (US$ Million)
Table 143. Global Veterinary Autogenous Vaccines Revenue Market Share by Type (2021-2026)
Table 144. Global Veterinary Autogenous Vaccines Revenue Market Share by Type (2027-2032)
Table 145. Global Veterinary Autogenous Vaccines Price by Type (2021-2026) & (US$/Unit)
Table 146. Global Veterinary Autogenous Vaccines Price by Type (2027-2032) & (US$/Unit)
Table 147. Global Veterinary Autogenous Vaccines Sales by Application (2021-2026) & (W Units)
Table 148. Global Veterinary Autogenous Vaccines Sales by Application (2027-2032) & (W Units)
Table 149. Global Veterinary Autogenous Vaccines Sales Market Share by Application (2021-2026)
Table 150. Global Veterinary Autogenous Vaccines Sales Market Share by Application (2027-2032)
Table 151. Global Veterinary Autogenous Vaccines Revenue by Application (2021-2026) & (US$ Million)
Table 152. Global Veterinary Autogenous Vaccines Revenue by Application (2027-2032) & (US$ Million)
Table 153. Global Veterinary Autogenous Vaccines Revenue Market Share by Application (2021-2026)
Table 154. Global Veterinary Autogenous Vaccines Revenue Market Share by Application (2027-2032)
Table 155. Global Veterinary Autogenous Vaccines Price by Application (2021-2026) & (US$/Unit)
Table 156. Global Veterinary Autogenous Vaccines Price by Application (2027-2032) & (US$/Unit)
Table 157. Key Raw Materials
Table 158. Raw Materials Key Suppliers
Table 159. Veterinary Autogenous Vaccines Distributors List
Table 160. Veterinary Autogenous Vaccines Customers List
Table 161. Veterinary Autogenous Vaccines Industry Trends
Table 162. Veterinary Autogenous Vaccines Industry Drivers
Table 163. Veterinary Autogenous Vaccines Industry Restraints
Table 164. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Veterinary Autogenous Vaccines Product Image
Figure 5. Global Veterinary Autogenous Vaccines Revenue (US$ Million), 2021 VS 2025 VS 2032
Figure 6. Global Veterinary Autogenous Vaccines Market Size (2021-2032) & (US$ Million)
Figure 7. Global Veterinary Autogenous Vaccines Sales (2021-2032) & (W Units)
Figure 8. Global Veterinary Autogenous Vaccines Average Price (US$/Unit) & (2021-2032)
Figure 9. Pet Vaccine Product Image
Figure 10. Livestock Vaccine Product Image
Figure 11. Research Facility Product Image
Figure 12. Ranches Product Image
Figure 13. Pet Clinic Product Image
Figure 14. Others Product Image
Figure 15. Global Veterinary Autogenous Vaccines Revenue Share by Manufacturers in 2025
Figure 16. Global Manufacturers of Veterinary Autogenous Vaccines, Manufacturing Sites & Headquarters
Figure 17. Global Top 5 and 10 Veterinary Autogenous Vaccines Players Market Share by Revenue in 2025
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 19. Global Veterinary Autogenous Vaccines Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Figure 20. Global Veterinary Autogenous Vaccines Sales by Region in 2025
Figure 21. Global Veterinary Autogenous Vaccines Revenue by Region in 2025
Figure 22. North America Veterinary Autogenous Vaccines Market Size by Country in 2025
Figure 23. North America Veterinary Autogenous Vaccines Sales Market Share by Country (2021-2032)
Figure 24. North America Veterinary Autogenous Vaccines Revenue Market Share by Country (2021-2032)
Figure 25. United States Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 26. Canada Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 27. Europe Veterinary Autogenous Vaccines Market Size by Country in 2025
Figure 28. Europe Veterinary Autogenous Vaccines Sales Market Share by Country (2021-2032)
Figure 29. Europe Veterinary Autogenous Vaccines Revenue Market Share by Country (2021-2032)
Figure 30. Germany Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 31. France Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 32. U.K. Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 33. Italy Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 34. Netherlands Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 35. Asia Pacific Veterinary Autogenous Vaccines Market Size by Country in 2025
Figure 36. Asia Pacific Veterinary Autogenous Vaccines Sales Market Share by Country (2021-2032)
Figure 37. Asia Pacific Veterinary Autogenous Vaccines Revenue Market Share by Country (2021-2032)
Figure 38. China Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 39. Japan Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 40. South Korea Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 41. India Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 42. Australia Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 43. China Taiwan Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 44. Southeast Asia Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 46. South America Veterinary Autogenous Vaccines Market Size by Country in 2025
Figure 47. South America Veterinary Autogenous Vaccines Sales Market Share by Country (2021-2032)
Figure 48. South America Veterinary Autogenous Vaccines Revenue Market Share by Country (2021-2032)
Figure 49. Mexico Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 50. Brazil Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 51. Argentina Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 52. Middle East and Africa Veterinary Autogenous Vaccines Market Size by Country in 2025
Figure 53. Middle East and Africa Veterinary Autogenous Vaccines Sales Market Share by Country (2021-2032)
Figure 54. Middle East and Africa Veterinary Autogenous Vaccines Revenue Market Share by Country (2021-2032)
Figure 55. Turkey Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 56. Saudi Arabia Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 57. UAE Veterinary Autogenous Vaccines Revenue Growth Rate (2021-2032) & (US$ Million)
Figure 58. Global Veterinary Autogenous Vaccines Sales Market Share by Type (2021-2032)
Figure 59. Global Veterinary Autogenous Vaccines Revenue Market Share by Type (2021-2032)
Figure 60. Global Veterinary Autogenous Vaccines Price (US$/Unit) by Type (2021-2032)
Figure 61. Global Veterinary Autogenous Vaccines Sales Market Share by Application (2021-2032)
Figure 62. Global Veterinary Autogenous Vaccines Revenue Market Share by Application (2021-2032)
Figure 63. Global Veterinary Autogenous Vaccines Price (US$/Unit) by Application (2021-2032)
Figure 64. Veterinary Autogenous Vaccines Value Chain
Figure 65. Veterinary Autogenous Vaccines Production Mode & Process
Figure 66. Direct Comparison with Distribution Share
Figure 67. Distributors Profiles
Figure 68. Veterinary Autogenous Vaccines Industry Opportunities and Challenges
提及公司
ZOETISVaxxinovaUVAXXPhibro Animal Health CorporationNewport LaboratoriesLOHMANN TIERZUCHTHygieia Biological LaboratoriesGenova LabsGallant Custom LaboratoriesEpitopixElanco Animal HealthDyntecDeltamune Animal HealthCeva BiovacBoehringer IngelheimBimedaAddison Biological Laboratory
量子訊息有限公司為 APO Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們